KR KRSNAA
Krsnaa Diagnostics Q2 2026
KRKRSNAA

Krsnaa Diagnostics Q2 FY26 results (Jul–Sep 2025) and concall

Healthcare · Concall AI · Call held 10 Nov 2025

Management summary

  • Krsnaa Diagnostics reported a strong Q2 FY26 with 11% YoY revenue growth to ₹206 crores and an 18% YoY EBITDA increase to ₹60 crores.
  • Operational efficiencies and retail expansion..
  • PAT grew 22% to ₹24 crores, with ROCE trending towards 15%.
  • While the retail segment saw 60% QoQ growth, it is yet to break even, and receivables remain elevated at 150 days, though efforts are underway to reduce them.

Source: Inve concall analysis and management guidance record.

Highlights

  • Revenue grew by 11% year-on-year to ₹206 crores, demonstrating robust performance.

  • EBITDA increased by an impressive 18% year-on-year to ₹60 crores, with margins expanding to 29%.

  • Profit after tax (PAT) rose by 22% year-on-year to ₹24 crores, achieving a 12% margin.

  • Retail business showed significant momentum with a 60% quarter-on-quarter growth, contributing approximately 8% of H1 FY26 revenues.

What they filed

₹ Cr · quarterly
Line itemQ3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue9 10 8 2
EBITDA48 53 50 58
Net profit22 21 20 23
How to read this

₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.

Guidance & targets

Revenue

  • Overall Revenue Growth Revenue · next year or two years · Medium confidence higher teens

Retail Revenue

  • Retail Revenue Contribution Retail Revenue · FY26 · High confidence 8-10%

Source: Inve Guidance Tracker — management targets and direct quotes from the earnings call transcript.

Q&A highlights

0 direct
Status of new tenders and pipeline Partial
With regards to pipeline, there are tenders in pipeline. But like we mentioned in the past, due to the competitive nature of these tenders, we will be disclosing the details as and when we come closer to the concluding of the process of the tendering different stages.

Analyst sought clarity on new tender wins and pipeline, which is crucial for future growth, but management provided a general response citing competitive nature.

Asked by Bala Murali Krishna

OPEX percentage for the retail business (RPL) Partial
So, in that sense, initially, it may be a little slower, but however, it is going to be very robust. And as and when we are scaling the newer heights and building our percentage contribution to the overall revenue, it will come down further.

Analyst inquired about the cost structure of the new retail segment, and management indicated initial higher costs due to brand building and accessibility, which would reduce with scale.

Asked by Bala Murali Krishna

Unlock risks & concerns, Q3 FY26 watchlist, and full call analysis

You’re reading a preview. Opening the full call uses 1 concall credit and unlocks:

  • 6 risks, concerns & management red flags
  • 5 watchlist triggers for Q3 FY26
  • +7 more guidance targets & verbatim management quotes
  • +6 more analyst Q&A exchanges & evasion checks
  • Capital allocation & full section-by-section narrative

Sign in to use your monthly call allowance.

Inve summary of a publicly available earnings call transcript; see how call summaries are prepared and our regulatory disclaimer. · Share on WhatsApp · Scorecard image